Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Approval    source : Www.globenewswire.com    save search

Foresight Granted Patent Approval in Japan for All-Weather and Lighting Conditions Vision System
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
FRSX | News | $1.14 54K twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 1.74% C: -0.87%

patent japan granted approval system vision for
Elys BMG Group Announces Approval for The Ugly Mug Sportsbook in Washington, DC.
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ELYS | News | $0.1351 130K twitter stocktwits trandingview |
Consumer Services
| Email alert Add to watchlist

approval group for
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
Published: 2024-04-17 (Crawled : 09:00) - globenewswire.com
BCRX | News | $4.68 2.18% 550K twitter stocktwits trandingview |
Health Technology
| | O: 2.97% H: 0.0% C: 0.0%

orladeyo health approval
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $144.86 0.06% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.28% C: -0.16%

stelara fda biosimilar approval teva
Provident Financial Services, Inc. Receives Federal Reserve Board Approval for its Merger with Lakeland Bancorp, Inc.
Published: 2024-04-11 (Crawled : 23:00) - globenewswire.com
PFS | $13.76 1.03% 58K twitter stocktwits trandingview |
Finance
| | O: 1.18% H: 3.5% C: 2.4%
LBAI | $11.4 1.24% 24K twitter stocktwits trandingview |
Finance
| | O: 0.36% H: 4.91% C: 3.84%

reserve approval for financial
BBSI Announces Board Approval of Planned Four-For-One Stock Split, Pending Stockholder Approval of an Increase in Authorized Shares of Common Stock
Published: 2024-04-10 (Crawled : 20:00) - globenewswire.com
BBSI | News | $121.83 1.04% 6.4K twitter stocktwits trandingview |
Commercial Services
| | O: 0.93% H: 0.0% C: -0.7%

authorized approval
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.425 -1.04% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.92% H: 3.41% C: 2.27%

ocu400 approval positive for therapy
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
VERO | $0.85 9.72% 38K twitter stocktwits trandingview |
Health Technology
| | O: 1.51% H: 0.0% C: -9.59%

approval for max
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
VERO | $0.85 9.72% 38K twitter stocktwits trandingview |
Health Technology
| | O: -1.59% H: 18.23% C: 17.74%

pro approval
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
Published: 2024-04-01 (Crawled : 10:00) - globenewswire.com
LQDA M | $13.89 0.22% 66K twitter stocktwits trandingview |
Health Technology
| | O: 2.99% H: 0.06% C: -3.74%

fda approval favorable update potential
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K twitter stocktwits trandingview |
Health Technology
| | O: -2.88% H: 6.93% C: 5.94%

approval
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
Published: 2024-03-27 (Crawled : 12:30) - globenewswire.com
ALLR | News | $1.32 -12.0% 460K twitter stocktwits trandingview |
n/a
| | O: 0.32% H: 2.87% C: 2.87%

approval cancer therapeutics advanced
ATHA Energy Announces 92 Energy Obtains Court Approval
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
NXE | $7.795 1.63% 970K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 0.13% H: 1.18% C: 1.18%

energy approval
UP Fintech Holding Limited’s Hong Kong Subsidiary Receives SFC Approval on Type 9 License to Provide Asset Management Services
Published: 2024-03-27 (Crawled : 10:00) - globenewswire.com
TIGR | $3.205 1.42% 100K twitter stocktwits trandingview |
Finance
| | O: -0.29% H: 2.21% C: 0.88%

management services license approval
Rail Vision Received Approval from Alstom to Install the AI Main Line system on its Locomotives
Published: 2024-03-26 (Crawled : 13:30) - globenewswire.com
RVSN | $1.04 0.97% 430K twitter stocktwits trandingview |
n/a
| | O: 7.5% H: 0.0% C: -14.53%
ALSMY | $1.51 650K twitter stocktwits trandingview |
Manufacturing
| | O: 0.71% H: 1.42% C: 1.42%

approval system vision
Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
CELU F | $3.31 9.7K twitter stocktwits trandingview |
| | O: 1.52% H: 0.0% C: -5.98%

biovance services approval system
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
Published: 2024-03-26 (Crawled : 06:00) - globenewswire.com
ARGX | $366.93 0.2% 85K twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.79% C: -0.29%

japan vyvgart approval
ATHA Energy Announces 92 Energy Obtains Shareholder Approval for Transaction
Published: 2024-03-25 (Crawled : 13:30) - globenewswire.com
NXE | $7.795 1.63% 970K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 0.65% H: 2.05% C: -2.18%

energy approval
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $124.095 -0.35% 660K twitter stocktwits trandingview |
Health Technology
| | O: -1.04% H: 1.6% C: 0.64%

awiqli approval treatment diabetes insulin
Breeze Holdings Acquisition Corp. Announces Nasdaq Panel Approval for Continued Listing to Complete Initial Business Combination by May 28, 2024
Published: 2024-03-20 (Crawled : 21:00) - globenewswire.com
BREZ | $11.4985 170 twitter stocktwits trandingview |
| | O: 0.51% H: 0.0% C: -0.51%

nasdaq business approval acquisition
Gainers vs Losers
83% 17%

Top 10 Gainers
AGBA | $0.7995 99.88% 73M twitter stocktwits trandingview |
Finance

BPTH | $6.21 91.67% 58M twitter stocktwits trandingview |
Health Technology

INVO | $1.36 78.95% 3.6M twitter stocktwits trandingview |
Health Technology

TIRX | $0.8258 70.34% 50M twitter stocktwits trandingview |

ISPC | $0.307 44.13% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...

SINT | $0.0504 35.12% 300M twitter stocktwits trandingview |
Health Technology

VTNR S | $1.295 32.25% 5.5M twitter stocktwits trandingview |
Industrial Services

ALRN | $5.53 30.12% 250K twitter stocktwits trandingview |
Health Technology

SMSI 4 | $2.53 29.74% 510K twitter stocktwits trandingview |
Technology Services

HOLO | $2.86 27.68% 28M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.